FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:1089-1090 April 14, 1994 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by The GUSTO Investigators Related Article by The GUSTO Angiographic Investigators

To the Editor: The GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) angiographic investigators (Nov. 25 issue)¹ concluded that normal coronary flow in the infarct-related artery early after myocardial infarction is associated with a sustained improvement in the ejection fraction, as compared with reduced flow or an absence of flow. They further demonstrated that accelerated treatment with recombinant tissue plasminogen activator (t-PA) resulted in early normal flow (at 90 minutes) more frequently than treatment with streptokinase and heparin or combination treatment with t-PA and streptokinase.

One might have expected that any degree of improvement in . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.